This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Vision-Sciences' EndoSheath(R) Technology Offers Patented Solution To "Nightmare Bacteria"

ORANGEBURG, N.Y., Jan. 13, 2014 (GLOBE NEWSWIRE) -- An outbreak of "Nightmare Bacteria," also known as the "Super Bug," has raised new alarm bells in the healthcare industry over patient safety. The concern stems from 44 newly reported cases of cross-contamination infections as a result of endoscopic procedures done at Advocate Lutheran General Hospital, located just outside of Chicago.*

"This type of outbreak not only undermines patient confidence, it creates stiff potential financial liabilities for hospitals and other healthcare facilities under the Affordable Care Act," said Howard Zauberman, President and Chief Executive Officer of Vision-Sciences, Inc. (Nasdaq:VSCI) – a company specializing in endoscopes that help safeguard patients from cross-contamination infections caused by conventional endoscopes.

Vision-Sciences ( www.visionsciences.com ) provides patented technology solutions that safeguard patients with a sterile cover, or EndoSheath® Technology , for its endoscopes. This prevents direct contact of the scope with the patient and reduces the risk of contracting infections from bacteria such as the Nightmare Bacteria as a result of endoscopic cross-contamination. In 20 years and with over 5 million procedures performed with EndoSheath® Technology, Vision-Sciences has never received a report of cross-contamination.

"We feel confident that our EndoSheath® Technology is a win-win for the healthcare facility and its patients. It is in our best interest to ensure that all healthcare professionals are aware of this alternative to conventional endoscopes while offering a cost cutting and liability reducing solution," said Lewis C. Pell, Chairman and Co-founder of Vision-Sciences.

Mr. Pell and Mr. Zauberman are available for in-person meetings or phone interviews. Please contact Mitch Kayden at (845) 709-5607 for more information and to set up an interview.

Important Summary Points

-- The Affordable Care Act creates potential liability for all healthcare facilities for hospital-acquired infections. Vision Sciences® technology offers an option for hospitals to reduce liability and lower costs/overhead.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7870 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs